Mesenchymal stromal cell activation by breast cancer secretomes in bioengineered 3D microenvironments
Open accessThe DOI matches its Crossref record; 85 of the 86 references it cites were found in a registry or an index.
Abstract
Mesenchymal stromal cells (MSCs) are key contributors of the tumour microenvironment and are known to promote cancer progression through reciprocal communication with cancer cells, but how they become activated is not fully understood. Here, we investigate how breast cancer cells from different stages of the metastatic cascade convert MSCs into tumour-associated MSCs (TA-MSCs) using unbiased, global approaches. Using mass spectrometry, we compared the secretomes of MCF-7 cells, invasive MDA-MB-231 cells, and sublines isolated from bone, lung, and brain metastases and identified ECM and exosome components associated with invasion and organ-specific metastasis. Next, we used synthetic hydrogels to investigate how these different secretomes activate MSCs in bioengineered 3D microenvironments. Using kinase activity profiling and RNA sequencing, we found that only MDA-MB-231 breast cancer secretomes convert MSCs into TA-MSCs, resulting in an immunomodulatory phenotype that was particularly prominent in response to bone-tropic cancer cells. We have investigated paracrine signalling from breast cancer cells to TA-MSCs in 3D, which may highlight new potential targets for anticancer therapy approaches aimed at targeting tumour stroma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures











Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Many studies have con fi rmed the interaction between MSCs and breast cancer cells [44,45].”
From 3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions (2021) · cites this paper as [45]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Cox, T. R., Rumney, R. M. H., Schoof, E. M., Perryman, L., Høye, A. M., Agrawal, A., Bird, D., Latif, N. A., Forrest, H., Evans, H. R., et al. (2015) · Nature · doi:10.1038/nature14492 · Cited by 482
Self-citationRetractedModerated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890 · cited 1×
“GO analysis was performed using DAVID (version 6.8) (71) against the Homo sapiens background where terms with fold enrichment ≥ 1.5, Bonferroni-corrected P - value 0.05, EASE score (modi fi ed Fisher ’ s exact test) 0.05, and at least two proteins per keyword were considered signi fi cantly…”
InfluentialHTSeq—a Python framework to work with high-throughput sequencing data
Anders, S., Pyl, P. T., & Huber, W. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btu638 · Cited by 21,464
Cox, J., & Mann, M. (2008) · Nature Biotechnology · doi:10.1038/nbt.1511 · Cited by 14,855
Smyth, G. K. (2004) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1027 · Cited by 11,829
The Warburg Effect: How Does it Benefit Cancer Cells?
Liberti, M. V., & Locasale, J. W. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.12.001 · Cited by 5,150 · cited 1×
“A high aerobic glycolytic activity is a hallmark of cancer and is known as the Warburg effect in cancer cells (44, 45).”
Macrophage plasticity, polarization, and function in health and disease
Shapouri‐Moghaddam, A., Mohammadian, S., Vazini, H., Taghadosi, M., Esmaeili, S., Mardani, F., Seifi, B., Mohammadi, A., Afshari, J. T., & Sahebkar, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26429 · Cited by 4,930
Cited by
3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions
Rodrigues, J., Heinrich, M. A., Teixeira, L. M., & Prakash, J. (2021) · Trends in Cancer · doi:10.1016/j.trecan.2020.10.009 · Cited by 405
Engineered hydrogels for mechanobiology
Blache, U., Ford, E. M., Ha, B., Rijns, L., Chaudhuri, O., Dankers, P. Y. W., Kloxin, A. M., Snedeker, J. G., & Gentleman, E. (2022) · Nature Reviews Methods Primers · doi:10.1038/s43586-022-00179-7 · Cited by 227
Self-citationHill, B. S., Sarnella, A., D’Avino, G., & Zannetti, A. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.07.028 · Cited by 156
Mesenchymal stem cell-derived exosome: A tumor regulator and carrier for targeted tumor therapy
Zhang, F., Guo, J., Zhang, Z., Qian, Y., Wang, G., Duan, M., Zhao, H., Yang, Z., & Jiang, X. (2022) · Cancer Letters · doi:10.1016/j.canlet.2021.11.015 · Cited by 127
Nielsen, S. R., Strøbech, J. E., Horton, E. R., Jackstadt, R., Laitala, A., Bravo, M. C., Maltese, G., Jensen, A. R. D., Reuten, R., Rafaeva, M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23731-7 · Cited by 125
Self-citationFrisbie, L., Buckanovich, R. J., & Coffman, L. (2022) · Stem Cells · doi:10.1093/stmcls/sxac036 · Cited by 101
Wang, M., Zhao, X., Qiu, R., Gong, Z., Huang, F., Yu, W., Shen, B., Sha, X., Dong, H., Huang, J., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01722-8 · Cited by 85
Fisher, S. A., Tam, R. Y., Fokina, A., Mahmoodi, M. M., Distefano, M. D., & Shoichet, M. S. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.01.032 · Cited by 78
Ritter, A., Kreis, N., Hoock, S. C., Solbach, C., Louwen, F., & Yuan, J. (2022) · Cancers · doi:10.3390/cancers14163908 · Cited by 72
“Moreover, both breast cancer cells and MSC/ASC-derived EVs are essential for the crosstalk between MSCs/ASCs and breast cancer cells [63,67,68].”
BackgroundThree-Dimensional 3D Culture Models in Gynecological and Breast Cancer Research
Salinas-Vera, Y. M., Valdés, J., Pérez‐Navarro, Y., Mandujano-Lázaro, G., Marchat, L. A., Ramos‐Payán, R., Núñez-Olvera, S. I., Pérez‐Plasencia, C., & López‐Camarillo, C. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.826113 · Cited by 81
Bhattacharya, A., Alam, K., Roy, N. S., Kaur, K., Kaity, S., Ravichandiran, V., & Roy, S. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02926-4 · Cited by 66
“Adipose progenitor cells have been shown to assemble the fibronectin (Fn) matrix in response to soluble factors secreted by breast cancer cells, leading to increased stiffness of the tumor stroma [151].”
BackgroundFibroblasts as Turned Agents in Cancer Progression
Wieder, R. (2023) · Cancers · doi:10.3390/cancers15072014 · Cited by 57
Proteomics and its applications in breast cancer.
Neagu, A.-N., Whitham, D., Buonanno, E., Jenkins, A., Alexa‐Stratulat, T., Tamba, B.-I., & Darie, C. C. (2021) · PubMed · Cited by 55
Horton, E. R., Vallmajó-Martín, Q., Martín, I., Snedeker, J. G., Ehrbar, M., & Blache, U. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.201901669 · Cited by 49
Self-citation3D Cell Cultures as Prospective Models to Study Extracellular Vesicles in Cancer
Bordanaba-Florit, G., Madarieta, I., Olalde, B., Falcón‐Pérez, J. M., & Royo, F. (2021) · Cancers · doi:10.3390/cancers13020307 · Cited by 49
“In contrast, MCF7 (considered a non-metastatic breast cancer cell line) -derived EVs failed to generate this phenotype in the MSCs culture [89].”
BackgroundFraming cancer progression: influence of the organ‐ and tumour‐specific matrisome
Rafaeva, M., & Erler, J. T. (2020) · FEBS Journal · doi:10.1111/febs.15223 · Cited by 50
Self-citationAhmadi, M., Mahmoodi, M., Shoaran, M., Nazari‐Khanamiri, F., & Rezaie, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213974 · Cited by 42
“This event can be induced by exosomes derived from tumor cells because exosomes contain pro-oncogenic factors that cause transcriptional and translational changes in normal MSCs [64].”
BackgroundSanmartin, M. C., Borzone, F. R., Giorello, M. B., Pacienza, N., Yannarelli, G., & Chasseing, N. A. (2021) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2021.103416 · Cited by 36
Liu, S., Zhang, F., Liang, Y., Wu, G., Liu, R., Li, X., Saw, P. E., & Yang, Z. (2023) · Science China Life Sciences · doi:10.1007/s11427-022-2329-7 · Cited by 35
“The most common organ metastasis for breast cancer is the lung, liver, bone, and brain (Blache et al., 2019; Mills, 2017).”
BackgroundThree-Dimensional in Vitro Models: A Promising Tool To Scale-Up Breast Cancer Research
Azimian, V., Rafiee, L., Sheikholeslam, M., Shariati, L., Vaseghi, G., Savoji, H., & Javanmard, S. H. (2022) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.2c00277 · Cited by 36
Kamdje, A. H. N., Etet, P. F. S., Simo, R. T., Vecchio, L., Lukong, K. E., & Krampera, M. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.545126 · Cited by 37
“When assessing how breast cancer cells from different stages of the metastatic cascade convert MSCs into tumorassociated MSCs, it was observed that only MDA-MB-231 breast cancer secretomes, but not MCF-7 cells or sublines isolated from bone, lung, and brain metastases, converted MSCs into tumor-associated MSCs in bioe…”
BackgroundMacdougall, L. J., Wiley, K. L., Kloxin, A. M., & Dove, A. P. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.04.046 · Cited by 31
Molecular insights into the interplay between adiposity, breast cancer and bone metastasis
Soni, S., Torvund, M., & Mandal, C. C. (2021) · Clinical & Experimental Metastasis · doi:10.1007/s10585-021-10076-0 · Cited by 30
Proteins Found in the Triple-Negative Breast Cancer Secretome and Their Therapeutic Potential
McHenry, P. R., & Prosperi, J. R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032100 · Cited by 25
“The secretome from the lung-, bone-, and brain-specific MDA-MB-231 cells showed organ-specific changes in protein expression, which suggests that a niche may be established for organ-specific metastatic spread [139].”
BackgroundFranzén, A. S., Raftery, M. J., & Pecher, G. (2022) · Cancers · doi:10.3390/cancers14133178 · Cited by 27
“It has also been shown that the tumor secretosome and the capacity to convert mesenchymal stromal cells to CAF differs between breast cell lines, and that this was linked to different phases of tumor progression [27].”
BackgroundCosta, S. A., Rodrigues, J., Vieira, C., Dias, S., Viegas, J. S. R., Castro, F., Sarmento, B. F. C. C., & Pereira, C. L. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.10.068 · Cited by 25
Exosome RNA Sequencing as a Tool in the Search for Cancer Biomarkers
Elkommos-Zakhary, M., Rajesh, N., & Beljanski, V. (2022) · Non-Coding RNA · doi:10.3390/ncrna8060075 · Cited by 28
Hamester, F., Stürken, C., Saygı, C., Qi, M., Legler, K., Gorzelanny, C., Robador, J. R., Schmalfeldt, B., Laakmann, E., Müller, V., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031900 · Cited by 23
“, who showed that the secretome of the brain-seeking BC subline is the least different from the parental cell line compared to other metastatic sublines (bone and lung) [45].”
BackgroundBhattacharya, T., Kumari, M., Kaur, K., Kaity, S., Arumugam, S., Ravichandiran, V., & Roy, S. (2024) · Journal of Materials Chemistry B · doi:10.1039/d4tb00680a · Cited by 21
Modeling Metastatic Colonization in a Decellularized Organ Scaffold‐Based Perfusion Bioreactor
Rafaeva, M., Horton, E. R., Jensen, A. R. D., Madsen, C. D., Reuten, R., Willacy, O., Brøchner, C. B., Jensen, T., Zornhagen, K. W., Crespo, M., et al. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202100684 · Cited by 19
Self-citationEngineering Biomaterials to Model Immune‐Tumor Interactions In Vitro
Skirzynska, A., Xue, C., & Shoichet, M. S. (2024) · Advanced Materials · doi:10.1002/adma.202310637 · Cited by 19
A Novel Approach for the Discovery of Biomarkers of Radiotherapy Response in Breast Cancer
Meehan, J., Gray, M., Martínez-Pérez, C., Kay, C., Wills, J. C., Kunkler, I. H., Dixon, J. M., & Turnbull, A. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11080796 · Cited by 17
Organ-Specific, Fibroblast-Derived Matrix as a Tool for Studying Breast Cancer Metastasis
Jensen, A. R. D., Horton, E. R., Blicher, L. H., Pietras, E. J., Steinhauer, C., Reuten, R., Schoof, E. M., & Erler, J. T. (2021) · Cancers · doi:10.3390/cancers13133331 · Cited by 14
“Fluorescence emitted was then imaged by a built-in CCD camera [33,34].”
MethodSelf-citationThe gut microbiota can be a potential regulator and treatment target of bone metastasis
Contino, K. F., Yadav, H., & Shiozawa, Y. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.114916 · Cited by 17
Wieleba, I., Wojas‐Krawczyk, K., Krawczyk, P. A., & Milanowski, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042261 · Cited by 14
Dieters‐Castator, D. Z., Dantonio, P. M., Piaseczny, M., Zhang, G., Liu, J., Kuljanin, M., Sherman, S. E., Jewer, M., Quesnel, K., Kang, E. Y., et al. (2021) · Neoplasia · doi:10.1016/j.neo.2021.02.004 · Cited by 11
“0) NODAL percentage (%) – Median (range) 50 (5-100) NA 3 (7.”
Functional Bioinformatics Analyses of the Matrisome and Integrin Adhesome
Horton, E. R. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0962-0_16 · Cited by 10
Self-citationKamdje, A. H. N., Etet, P. F. S., Simo, R. T., Vecchio, L., Lukong, K. E., & Krampera, M. (2020) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2020.0133 · Cited by 9
Kastora, S. L., Kounidas, G., Speirs, V., & Masannat, Y. (2022) · Cancers · doi:10.3390/cancers14163854 · Cited by 5
“Brown cell (grade III, cluster 2) interactions: HSPG2 and LOXL2 interaction with IGFB3 [38,73].”
BackgroundThe role of mesenchymal cells in cholangiocarcinoma
Sueca-Comes, M., Rusu, E. C., Ashworth, J. C., Collier, P., Probert, C., Ritchie, A., Meakin, M. L., Mongan, N. P., Egbuniwe, I. U., Andersen, J. B., et al. (2024) · Disease Models & Mechanisms · doi:10.1242/dmm.050716 · Cited by 5
“…them autonomous, for example with constitutively activated growth receptors (Du and Lovly, 2018), and thus they do not require paracrine signals or may be unable to provide signals required by MSCs to differentiate into activated CAFs (Shamai et al., 2019; Blache et al., 2019; Wang et al., 2021).”
Engineered hydrogels for mechanobiology
(2022) · Nature Reviews Methods Primers · doi:10.1038/s43586-022-00189-5 · Cited by 3
Ebrahimnejad, P., Mohammadi, Z., Ahmadi, M., Amirkhanloo, S., Babaei, A., Asare‐Addo, K., & Nokhodchi, A. (2022) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.2022043898 · Cited by 3
METTL3 regulates exocytosis independently of m 6 A
Esteva-Socias, M., Bhattarai, D. P., Achour, C., Baidya, P., Kumari, K., Fontanari, G., Seier, K., Pace, H. P., Malla, S., Zhu, S., et al. (2026) · Science Advances · doi:10.1126/sciadv.adz2434 · Cited by 2
Mohammad-Rezaei, M., Shafaghat, Z., Noroozbeygi, M., Velu, P., Safaee, M., Heiranizadeh, N., & Safari, E. (2026) · Clinical & Translational Oncology · doi:10.1007/s12094-026-04450-1 · Cited by 1
Mierzejewski, M., Paplińska‐Goryca, M., & Krenke, R. (2022) · Medical Science Monitor · doi:10.12659/msm.936065
“The paracrine effect of the soluble factors secreted by tumor cells on other cells in the tumor microenvironment has been well described in neoplasms such as breast cancer [36].”
BackgroundThe role of breast cancer derived-exosomes in the tumour micro-environment
Ham, S. (2021) · Queensland University of Technology · doi:10.5204/thesis.eprints.208432
Tissue Engineered Models of Metastasis: Focus on Bone Metastasis
Sempertegui, N. D., & Fischbach, C. (2022) · Royal Society of Chemistry eBooks · doi:10.1039/9781839166013-00384
Topalova, L., Stoyanova, T., García-Parra, N., Ribelles, J. L. G., Todinova, S. J., & Altankov, G. (2026) · Cells · doi:10.3390/cells15191775
“More broadly, previous studies of tumor-mediated stromal activation have predominantly characterized molecular and biochemical endpoints, including transcriptional changes in CAF and ECM-associated genes, expression or activity of matrix-remodeling enzymes, and proteomic alterations [34,41].”
Metadata
- Authors
- Blache, U., Horton, E. R., Xia, T., Schoof, E. M., Blicher, L. H., Schönenberger, A., Snedeker, J. G., Martin, I., Erler, J. T., & Ehrbar, M.
- Affiliations
- University of Zurich (CH)
- University of Copenhagen (DK)
- Technical University of Denmark (DK)
- Institute for Biomechanics, Eidgenössische Technische Hochschule Zurich, Zurich, Switzerland
- Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland
- Corresponding author
- Erler, Janine T
- Ehrbar, Martin
- Venue
- Life Science Alliance
- Publisher
- Life Science Alliance, LLC
- Published
- 2019-06
- Volume
- 2
- Issue
- 3
- Pages
- e201900304
- ISSN
- 2575-1077 (ISSN-L)
- PMC
- PMC6549139
- OpenAlex
- W2948778357
- Cited by
- 49
- References
- 86
- Citations by year
- 2026: 3 · 2024: 4 · 2023: 5 · 2022: 15 · 2021: 12 · 2020: 7 · 2019: 1
- FWCI
- 4.81
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Life Science Alliance (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Technical University of Denmark, DTU Orbit (Technical University of Denmark, DTU) (submittedVersion, cc-by)
- Repository for Publications and Research Data (ETH Zurich) (submittedVersion, cc-by)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by)
- ETH Zürich Research Collection (cc-by)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- European Research Council (ERC-2015-CoG-682881-MATRICAN)
- European Molecular Biology Organization (ATLF 922-2016)
- Danish Cancer Society (R204-A12445)
- European Union's Seventh Framework Programme (607868)
- Swiss National Science Foundation (310030-169808/1)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- mesenchymal stem cells, breast cancer, secretome, paracrine signaling, 3D microenvironment, synthetic hydrogels, exosomes, extracellular matrix, organ-specific metastasis, bone metastasis, immunomodulation, MDA-MB-231 cells, MCF-7 cells, tumor microenvironment, tumor stroma
- MeSH terms
- Breast Neoplasms, Chromatography, Liquid, Female, Humans, Mass Spectrometry, Tumor Cells, Cultured, Biomarkers, Cell Culture Techniques, Proteome, Gene Expression Profiling, Proteomics, Cell Line, Tumor, Metabolomics, Metabolome, Tumor Microenvironment, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.